These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches. Saddala MS, Huang H. J Transl Med; 2019 Jul 02; 17(1):215. PubMed ID: 31266509 [Abstract] [Full Text] [Related]
6. Pharmacophore modeling and virtual screening in search of novel Bruton's tyrosine kinase inhibitors. Sharma A, Thelma BK. J Mol Model; 2019 Jun 06; 25(7):179. PubMed ID: 31172362 [Abstract] [Full Text] [Related]
7. Discovery of highly potent TNFα inhibitors using virtual screen. Shen Q, Chen J, Wang Q, Deng X, Liu Y, Lai L. Eur J Med Chem; 2014 Oct 06; 85():119-26. PubMed ID: 25078315 [Abstract] [Full Text] [Related]
19. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2. Tutumlu G, Dogan B, Avsar T, Orhan MD, Calis S, Durdagi S. Front Chem; 2020 Nov 24; 8():167. PubMed ID: 32328476 [Abstract] [Full Text] [Related]
20. 3D-QSAR pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation toward identifying lead compounds for NS2B-NS3 protease inhibitors. Luo PH, Zhang XR, Huang L, Yuan L, Zhou XZ, Gao X, Li LS. J Recept Signal Transduct Res; 2017 Oct 24; 37(5):481-492. PubMed ID: 28758854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]